CryoLife's next-gen hemodialysis device gains 510(k) clearance

04/5/2013 | RTT News

The FDA has cleared CryoLife to market its Hemodialysis Reliable Outflow, or HeRO, system. The next-generation device, set to be released in the fourth quarter, provides long-term AV access for central venous stenosis patients undergoing hemodialysis and improves on the original version with an adaptor for integration with other dialysis access grafts.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care